What is CBD (Cannabidiol)?

Everything you need to know about the world’s most studied cannabinoid, in one place — written for curious beginners and experienced users alike.

You’ve seen it in coffee shops and pharmacies. It’s in oil droppers, gummy bears, dog treats, and sports creams. According to a 2023 Healthline survey, 25% of American adults have tried or are interested in trying CBD products (Healthline, 2023). Yet for all its ubiquity, genuine confusion about what CBD is, what it does, and how to use it responsibly remains widespread.

This guide cuts through the noise. We’ve synthesized the best available science alongside the most common real-world questions to give you a complete, honest, and research-grounded overview of cannabidiol.

What Is CBD?

Cannabidiol (CBD) is a naturally occurring chemical compound found in the cannabis plant (Cannabis sativa L.). It is the second-most abundant cannabinoid in the plant after THC, and one of more than 100 distinct cannabinoids identified in cannabis to date (Weedmaps, 2024). Unlike THC, CBD is non-intoxicating — it does not produce a “high” or alter your mental state.

CBD can be extracted from both hemp and marijuana, which are both varieties of Cannabis sativa. Chemically, the CBD molecule is identical regardless of its source. However, most consumer CBD products are derived from industrial hemp, which is legally defined in the United States as cannabis containing less than 0.3% THC by dry weight (Veriheal, 2024).

CBD vs. THC: Key Differences

CBD and THC are the two most abundant and most studied cannabinoids in cannabis. They share a nearly identical molecular formula — both are C₂₁H₃₀O₂ — but their three-dimensional structures differ, and those structural differences produce dramatically different effects in the body.

Property	CBD	THC
Psychoactive (“high”)	No	Yes
CB1 receptor binding	Weak / allosteric modulator	Direct agonist
Federally legal (hemp-derived)	Yes (under 2018 Farm Bill)	No (Schedule I)
FDA-approved drug	Yes — Epidiolex	Yes — Marinol (dronabinol), Syndros
Addiction potential	None identified	Yes, with heavy use
Anxiety effect	Anxiolytic (reduces anxiety)	Can increase anxiety at high doses
Drug test detection	Unlikely (tests target THC)	Yes

One important nuance: CBD can actually moderate some of THC’s effects. It can lessen or neutralize the psychoactive and anxiety-producing effects of THC, depending on the ratio consumed — which is one reason why high-CBD, balanced-ratio products are used by people who want cannabis’s therapeutic properties with reduced intoxication (Project CBD, 2024).

A Brief History of CBD

Cannabis has been used medicinally for thousands of years, but the scientific story of CBD is much more recent. In 1940, Harvard-trained organic chemist Roger Adams first successfully isolated CBD from cannabis — though at the time, neither its structure nor its effects were fully understood (Weedmaps, 2024).

It wasn’t until 1963 that Israeli chemist Raphael Mechoulam — now widely known as the “godfather of cannabis research” — and colleague Yechiel Shvo elucidated the complete chemical structure of CBD. The following year, Mechoulam’s team identified THC as the plant’s primary psychoactive compound (Martinez Naya et al., 2023; Pertwee, 2006).

Despite this early groundwork, CBD research stagnated for decades due to legal restrictions and the misconception that CBD was pharmacologically inert. The landscape shifted dramatically in the 2010s, when high-profile cases of CBD dramatically reducing seizures in children with Dravet syndrome captured public and scientific attention. In 2018, two landmark events reshaped the CBD landscape: the Farm Bill legalized hemp-derived CBD nationally, and the FDA approved Epidiolex — the first plant-derived cannabinoid medicine in U.S. history (Harvard Health Publishing, 2024).

How CBD Works: The Endocannabinoid System

To understand CBD, you need to understand the system it works with: the endocannabinoid system (ECS).

The ECS is a complex biological signaling network found throughout the body — in the brain, organs, immune cells, and peripheral nervous system. Its job is to maintain homeostasis, the body’s internal balance. It regulates processes including mood, sleep, appetite, pain perception, immune response, and memory (Leafly, 2021; HempWell, 2024).

The ECS has three core components: endocannabinoids (cannabinoids naturally produced by the body, like anandamide and 2-AG), receptors (primarily CB1, concentrated in the brain and central nervous system, and CB2, concentrated in the immune system and peripheral tissues), and enzymes that synthesize and break down endocannabinoids.

CBD interacts with this system in multiple ways — but not in the same way as THC, which directly activates CB1 receptors to produce intoxication. Instead, CBD’s pharmacology is remarkably broad. Researchers have identified approximately 56 distinct molecular targets for CBD (Castillo-Arellano et al., 2023), including:

• Allosteric modulation of CB1/CB2 receptors — CBD can change how these receptors respond to other compounds without directly activating them
• 5-HT₁A serotonin receptor agonism — contributing to anxiolytic and antidepressant effects
• TRPV1 and other TRP channel activation — involved in pain and inflammation signaling
• FAAH enzyme inhibition — slowing the breakdown of anandamide, raising its levels in the brain
• PPARγ agonism — influencing inflammation, metabolism, and cell differentiation
• Opioid, dopamine, and serotonin receptor modulation — explaining CBD’s broad effects on mood, pain, and addiction (Leafly, 2021)

This multi-target profile is both what makes CBD so therapeutically interesting and why it’s so difficult to reduce to a simple mechanism of action.

Potential Benefits & What the Research Shows

CBD has been studied across a wide range of conditions. The strength of evidence varies considerably — from the gold standard of FDA approval in epilepsy to very early-stage research in other areas. Here’s an honest breakdown:

Strong Evidence Epilepsy

This is CBD’s most solidly evidenced application. Multiple randomized controlled trials demonstrated significant seizure reduction in patients with Dravet syndrome and Lennox-Gastaut syndrome, leading to FDA approval of Epidiolex in 2018. The indication has since been expanded to include tuberous sclerosis complex. Notably, the anticonvulsant mechanism appears to operate largely independently of cannabinoid receptors (Harvard Health Publishing, 2024; Martinez Naya et al., 2023).

Moderate Evidence Anxiety

A 2024 systematic review and meta-analysis of eight clinical trials involving 316 participants found a statistically significant and substantial impact of CBD on anxiety, with a considerable effect size (Hedges’ g = −0.92; Kayser et al., 2024). Animal studies and human self-reports consistently support an anxiolytic effect, primarily mediated through 5-HT₁A serotonin receptor activity. Clinical trial evidence is promising but still limited by small sample sizes (Harvard Health Publishing, 2024).

Moderate Evidence Pain & Inflammation

A 2024 systematic review applying PRISMA guidelines analyzed 40 clinical and preclinical studies and concluded there is sufficient evidence for CBD as a potential treatment for chronic pain, neuropathic pain, osteoarthritis, and acute inflammatory conditions — with no significant adverse effects or treatment rejections reported (Casédas et al., 2024). Animal studies suggest CBD applied topically may reduce pain and inflammation associated with arthritis. Human clinical evidence remains more limited than for THC/CBD combination products (Harvard Health Publishing, 2024).

Moderate Evidence Sleep

Studies suggest CBD may help with both falling and staying asleep, in part by addressing underlying conditions like chronic pain and anxiety that disrupt sleep. A broader review found substantial evidence for CBD in stress-related sleep disruption (Aviram & Samuelly-Leichtag, 2022; Harvard Health Publishing, 2024).

Emerging Evidence Neurological Conditions

CBD has been studied in Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with preclinical data suggesting neuroprotective, anti-inflammatory, and antioxidant effects (Ibarra-Lecue et al., 2021). Human clinical evidence in these areas remains in early stages.

Emerging Evidence Substance Use & Addiction

CBD is currently under investigation for reducing drug relapse and managing addiction disorders, particularly due to its effects on dopamine and opioid receptor signaling (Ibarra-Lecue et al., 2021). Several clinicians have noted growing body of preclinical and clinical evidence supporting CBD’s potential role for opioid addiction (Prud’homme et al., 2015, as cited in Bauer et al., 2019).

Types of CBD Products

CBD is available in more delivery formats than almost any other supplement. The right form depends on what you’re trying to achieve, how quickly you need effects, and personal preference.

Full-Spectrum vs. Broad-Spectrum vs. Isolate

When shopping for CBD, you’ll encounter three main types. Understanding the differences matters for both effectiveness and drug test concerns.

Full-Spectrum CBD contains all the naturally occurring compounds in the cannabis plant — including CBD, trace amounts of THC (up to 0.3%), other cannabinoids like CBG and CBN, terpenes, and flavonoids. It is most likely to produce the “entourage effect,” where cannabinoids and terpenes work synergistically to enhance each other’s therapeutic properties (Weedmaps, 2024).

Broad-Spectrum CBD is similar to full-spectrum but with THC reduced to non-detectable levels (typically <0.01%). It retains other cannabinoids and terpenes, offering some entourage effect benefits without the risk of THC exposure (Weedmaps, 2024).

CBD Isolate is the purest form — 99%+ pure CBD, with all other compounds removed through additional processing. It results in a white crystalline powder or oil with no detectable THC. Best for those who need to strictly avoid THC, want precise dosing, or are sensitive to other cannabinoids (Weedmaps, 2024).

Bioavailability: Does the Form Matter?

Yes — significantly. Bioavailability refers to what percentage of the CBD you consume actually reaches your bloodstream and becomes active. This varies dramatically by delivery method:

Delivery Method	Bioavailability	Onset Time
Inhalation (vape/smoke)	11–45% (avg ~31%)	1–5 minutes
Sublingual (oil under tongue)	~12–35%	15–45 minutes
Oral — fed (with food)	36–57%	45–90 minutes
Oral — fasted (empty stomach)	~6%	45–90 minutes
Transdermal patch	Variable — slow release	Hours
Topical (cream/lotion)	Minimal systemic absorption	Local only

The most important takeaway here is often overlooked: taking oral CBD with a high-fat meal can increase systemic absorption by up to 10-fold compared to taking it fasted. This alone could explain why some people “feel nothing” from oral CBD products (Wikipedia contributors, 2025). A newer format — liposomal CBD — surrounds the CBD in a lipid layer that the body can more easily absorb, improving bioavailability beyond standard oral formulations (Weedmaps, 2024).

Dosing: How Much Should You Take?

CBD dosing is one of the least standardized aspects of the field, and for good reason: response varies considerably by body weight, metabolism, the condition being addressed, the delivery method, and the individual. There is no universal recommended dose for non-prescription CBD.

That said, a few practical principles emerge from both research and clinical guidance:

• Start low and go slow. Most practitioners recommend beginning with 5–10 mg per day and increasing gradually until you find a dose that works (Leafly, 2021; Weedmaps, 2024).
• Be consistent. CBD often works best with consistent daily use rather than as-needed dosing, particularly for anxiety, sleep, and inflammation.
• There may be a “sweet spot.” Research suggests CBD has a bell-shaped dose-response curve — too little and too much may both be less effective than a moderate dose. More is not necessarily better (Leafly, 2021).
• Clinical doses are much higher than consumer products. In the Epidiolex trials, doses ranged from 5–20 mg/kg/day — far exceeding what’s found in typical over-the-counter products.
• Take oral CBD with food. Given the bioavailability data, taking oil or capsules with a fat-containing meal can substantially improve absorption.

Side Effects & Safety

CBD has a favorable safety profile and is generally well-tolerated. The World Health Organization stated in a landmark 2017 report that CBD “exhibits no effects indicative of any abuse or dependence potential” and that “to date, there is no evidence of public health related problems associated with the use of pure CBD” (as cited in Harvard Health Publishing, 2024).

That said, CBD is not without potential side effects, particularly at higher doses:

Common (mild) side effects: diarrhea, fatigue, changes in appetite, dry mouth, dizziness (WebMD, 2024; Weedmaps, 2024).

Less common but serious side effects at prescription doses: liver enzyme elevations (particularly when combined with valproate), suicidal ideation (rare, flagged in Epidiolex prescribing information), and cannabinoid hyperemesis syndrome (CHS) in some users (WebMD, 2024).

Drug Interactions

This is one of the most clinically important considerations for CBD, and one that is frequently underemphasized in consumer marketing. CBD inhibits cytochrome P450 enzymes — particularly CYP2C19 and CYP3A4 — which are responsible for metabolizing a large percentage of commonly used medications (Martinez Naya et al., 2023).

Drugs that may be affected include blood thinners (warfarin), certain antiepileptics (clobazam, valproate), antidepressants, antifungals, and proton pump inhibitors, among others. When CBD inhibits the metabolism of these drugs, their blood levels can rise, potentially increasing both effectiveness and side effects.

Always consult a physician or pharmacist before combining CBD with any prescription medication.

Will CBD Show Up on a Drug Test?

In most cases, pure CBD will not trigger a positive drug test. Standard employment drug tests screen for THC metabolites, not CBD. However, there are important caveats (Weedmaps, 2024):

• Full-spectrum products contain trace amounts of THC (up to 0.3%). With regular use of high doses, THC can accumulate in fatty tissues and potentially trigger a positive test.
• Mislabeled products are a documented problem. Studies have found that many over-the-counter CBD products contain more THC than stated on the label.
• Broad-spectrum or isolate products carry significantly lower risk.

If drug testing is a concern, opt for CBD isolate or verified broad-spectrum products from companies with up-to-date Certificates of Analysis (COAs) from third-party labs.

Legality in the United States

The legal status of CBD in the U.S. is more nuanced than most people realize. The 2018 Farm Bill legalized hemp and hemp-derived products — including CBD — at the federal level, removing them from the Controlled Substances Act, provided they contain less than 0.3% THC (Harvard Health Publishing, 2024; Veriheal, 2024).

However, several important complications remain. The FDA does not currently recognize CBD as a legal dietary supplement or food additive, even if it’s derived from hemp. The FDA has only approved one CBD product: Epidiolex. Secondly, state laws vary — a handful of states have additional restrictions on CBD products. And finally, cannabis-derived CBD (from marijuana rather than hemp) remains federally illegal under Schedule I of the Controlled Substances Act, even though the molecule is chemically identical to hemp-derived CBD (Leafly, 2021).

How to Choose a Quality CBD Product

The CBD market is largely unregulated, which means product quality varies enormously. Multiple studies have found that a significant percentage of CBD products on the market are mislabeled — containing either more or less CBD than advertised, or more THC than the legal limit. Here’s what to look for (Bauer et al., 2019; Healthline, 2023):

• Certificate of Analysis (COA). Any reputable manufacturer posts up-to-date, third-party lab results online. The COA should confirm cannabinoid content and screen for pesticides, heavy metals, and solvents. Look for a COA dated within the past year.
• U.S.-grown hemp. American hemp is subject to agricultural regulations and testing requirements that many international sources are not.
• Extraction method. CO₂ extraction is the gold standard — it produces clean, solvent-free CBD without leaving harmful residues (Veriheal, 2024).
• Transparent labeling. The product should clearly state the total CBD content per serving and per container, the type of CBD (isolate, broad-spectrum, full-spectrum), and all ingredients.
• Avoid health claims. Companies making specific medical claims about their CBD products are violating FDA regulations — a red flag for overall quality practices.

Frequently Asked Questions

The Bottom Line

CBD is a genuinely remarkable molecule — one of over 100 cannabinoids in cannabis, but by far the most studied, the most legally accessible, and the most clinically validated for therapeutic use. Its FDA-approved efficacy in epilepsy is real and significant. Its evidence in anxiety, sleep, and pain is promising and growing. Its safety profile is favorable. And its non-psychoactive, non-addictive nature makes it accessible to people who would never consider traditional cannabis use.

At the same time, the CBD consumer market is a largely unregulated space where product quality is inconsistent, health claims often outpace evidence, and the gap between pharmaceutical-grade CBD and a gas station gummy is enormous. Approaching CBD with informed skepticism — reading COAs, understanding bioavailability, being realistic about evidence strength, and talking to a doctor if you’re on medications — is the difference between using it well and wasting money or taking unnecessary risks.

The science is real. Use it as your guide.

Nothing in this article constitutes medical advice. Always consult a qualified healthcare provider before beginning any new supplement regimen, especially if you take prescription medications or have an existing medical condition.

Back to List of Cannabinoids